Anlotinib Combined With Docetaxel For Advanced Non-Small Cell Lung Cancer After The Failure Of Platinum-Based Doublet-Chemotherapy
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Catequentinib (Primary) ; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms ACDFNSCLC
Most Recent Events
- 17 Nov 2018 New trial record